Luxor has developed advanced testing solutions to address the overdose crisis associated with substances including bromazolam, tianeptine, xylazine, and nitazenes, providing healthcare professionals with support to develop effective treatment plans. These testing solutions are designed to provide precise detection of hazardous substances in easily collected body fluids such as urine and oral fluids. The test menu is regularly updated to address evolving drug trends. Built to deliver rapid turnaround times within 24 to 48 hours, the tests help enable immediate intervention in emergency situations.